Shanshan Wang, MD, PhD
- Neural Stem Cells
- Parkinson’s Disease
Shanshan Wang, MD, PhD, graduated as an M.D. from Department of Clinical Medicine, Medical School of Zhejiang University, in Hangzhou, China in 1993. She completed her fellowship at The Second Hospital of Zhejiang Province. Then she worked as a physician in the Department of Internal Medicine in Taizhou hospital 3 years. From 1996 to 1999, she studied and worked in the Department of Cardiovascular Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, obtaining her Master’s Degree in 1999. She joined the Lab of Cardiovascular Disease, Key Lab of Biochemistry and Clinic of the National Engineering Research Center, Huashan hospital, college of medicine, Fudan University , Shanghai, China in Sep 1999, and received her PhD degree in 2002. From July 2002, she worked as a Physician and Research Associate in the Department of Cardiovascular Disease, Dongfang Hospital, Tongji University, Shanghai, China, until she moved to the U.S.A. and joined Dr. Steindler’s lab in Feb, 2004.
In her Ph.D thesis, she tried to screen drugs that can stimulate angiogenesis from Chinese herbs using CAM (chick embryo chorioallantoic membrane) and microvascular endothelial cell models. The molecular mechanism was then studied using immunohistological method and molecular biology techniques (RT-PCR, northern blot, and in situ hybridization). In the Department of Neuroscience and Neurosurgery, University of Florida, her work focuses on stem cell (mouse embryonic stem cells, adult brain-derived mouse/human stem cells, disease/patient-specific human neural stem cell including brain tumor-derived stem cells and parkinson’s patients’ neural stem cells) characterization, drug testing/analysis on cultured human neural stem cell models and xenograft animal models. Dr. Wang’s long term research interest is to understand the etiology of neurodegenerative disease like PD and AD, the relationship of neurogenesis and angiogenesis in the brain, and to test stem cell treatments for parkinson’s disease and brain tumors.